Ecstasy Therapy: Bad trip

The Maine senator has dodged decades of attacks, but President Trump’s low approval ratings could be her political deathblow. This episode was produced by Avishay Artsy and Dustin DeSoto, edited by Amina Al-Sadi, fact-checked by Gabriel Dunatov, engineered by David Tatasciore and ...  Show more

Men and women are trying to maximize their reproductive health due to anxieties around declining fertility trends. But are we taking “embryomaxxing” too far? This episode was produced by Miles Bryan, edited by Avishay Artsy, fact-checked by Melissa Hirsch, engineered by David Tat ...  Show more

The FDA is about to announce whether it’s going to approve MDMA as a treatment for PTSD. Our friends at Today, Explained explore what this kind of therapy looks like, and why it’s so controversial. For show transcripts, go to vox.com/unxtranscripts For more, go to vox.com/unexpla ...  Show more

In the ‘80s and ‘90s, MDMA (also known as molly or ecstasy) was dismissed as a club drug and became the target of anti-drug propaganda. Today, it’s on the brink of being legalized for use in clinical therapy to treat conditions like PTSD. How did that happen? And what have we lea ...  Show more

Bad trips, anti-drug PSAs, and the crackdown under the Controlled Substances Act of 1970 helped stigmatize psychedelics in the U.S. But now, there’s renewed clinical inquiry into whether these drugs can ease emotional trauma. To understand the future of psychedelics, Audie calls ...  Show more

Send us Fan MailThe path to FDA approved prescribable medicine has been a long and precarious one for psychedelics. However, recent reports by some of the major players in the psychedelic medicine space show promising results from clinical trials involving psilocybin and 5-MeO-DM ...  Show more